Published in Healthcare Finance, Tax and Law Weekly, February 14th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Coloplast.
Report 1: Coloplast, which develops ostomy products, emerged as a stronger business from the 2005/06 financial year, said CEO Sten Scheibye.
"Our organic growth was in line with the expectations we announced at the end of the third quarter, and our EBIT margin was just over 13%. This is a strong performance, considering the fact that the financial impact of the acquisition of Mentor's urology business lowered our operating profit by about DKK 280m. Our business is enjoying...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.